Hellman & Friedman is reportedly looking to sell the drug-eluting stent pioneer for about $9 billion, according to a report ...

There is plenty of opportunity for medtech manufacturers in Asia, but first you need to know how to avoid costly pitfalls.

Generative AI in medtech raises questions on safety, validation, and regulatory challenges, explored in MD&M West's "GenMLP" ...

Launched in 2021, Boston-based Eyebot places its vision testing technology in popular sites like schools, grocery stores, and ...

Project Medtech’s Lindsey Dinneen discusses the Leadership Summit set to occur at MD&M West next month. Good leadership ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

As AI adoption accelerates across life sciences, many organizations are discovering that pilots alone do not deliver impact. This trends brief explores four critical AI shifts shaping quality and ...

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...